Logo image of PDYN

PALLADYNE AI CORP (PDYN) Stock Fundamental Analysis

NASDAQ:PDYN - Nasdaq - US80359A2050 - Common Stock - Currency: USD

10.73  +0.64 (+6.34%)

After market: 10.72 -0.01 (-0.09%)

Fundamental Rating

3

Overall PDYN gets a fundamental rating of 3 out of 10. We evaluated PDYN against 127 industry peers in the Machinery industry. While PDYN has a great health rating, there are worries on its profitability. PDYN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PDYN has reported negative net income.
PDYN had a negative operating cash flow in the past year.
PDYN Yearly Net Income VS EBIT VS OCF VS FCFPDYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -67.34%, PDYN is doing worse than 91.34% of the companies in the same industry.
Looking at the Return On Equity, with a value of -150.64%, PDYN is doing worse than 87.40% of the companies in the same industry.
Industry RankSector Rank
ROA -67.34%
ROE -150.64%
ROIC N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PDYN Yearly ROA, ROE, ROICPDYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

PDYN has a Gross Margin of 67.71%. This is amongst the best in the industry. PDYN outperforms 99.21% of its industry peers.
PDYN's Gross Margin has improved in the last couple of years.
PDYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
PDYN Yearly Profit, Operating, Gross MarginsPDYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

7

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PDYN has been increased compared to 1 year ago.
PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PDYN Yearly Shares OutstandingPDYN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
PDYN Yearly Total Debt VS Total AssetsPDYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PDYN has an Altman-Z score of -4.58. This is a bad value and indicates that PDYN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.58, PDYN is not doing good in the industry: 90.55% of the companies in the same industry are doing better.
There is no outstanding debt for PDYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.58
ROIC/WACCN/A
WACC9.81%
PDYN Yearly LT Debt VS Equity VS FCFPDYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 16.03 indicates that PDYN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 16.03, PDYN belongs to the best of the industry, outperforming 98.43% of the companies in the same industry.
A Quick Ratio of 16.00 indicates that PDYN has no problem at all paying its short term obligations.
The Quick ratio of PDYN (16.00) is better than 98.43% of its industry peers.
Industry RankSector Rank
Current Ratio 16.03
Quick Ratio 16
PDYN Yearly Current Assets VS Current LiabilitesPDYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

PDYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.83%, which is quite impressive.
PDYN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.95%.
Measured over the past years, PDYN shows a quite strong growth in Revenue. The Revenue has been growing by 15.33% on average per year.
EPS 1Y (TTM)55.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-50.29%

3.2 Future

Based on estimates for the next years, PDYN will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.31% on average per year.
PDYN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.50% yearly.
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PDYN Yearly Revenue VS EstimatesPDYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M
PDYN Yearly EPS VS EstimatesPDYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PDYN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PDYN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PDYN Price Earnings VS Forward Price EarningsPDYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDYN Per share dataPDYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as PDYN's earnings are expected to grow with 17.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PDYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PALLADYNE AI CORP

NASDAQ:PDYN (7/23/2025, 8:00:00 PM)

After market: 10.72 -0.01 (-0.09%)

10.73

+0.64 (+6.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners12.29%
Inst Owner ChangeN/A
Ins Owners22.78%
Ins Owner Change28.88%
Market Cap383.17M
Analysts82.86
Price Target15.3 (42.59%)
Short Float %19.43%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-304.99%
Min EPS beat(2)-635.29%
Max EPS beat(2)25.3%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2%
Min Revenue beat(2)-43.71%
Max Revenue beat(2)39.71%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.28
P/FCF N/A
P/OCF N/A
P/B 13.54
P/tB 13.54
EV/EBITDA N/A
EPS(TTM)-1.74
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.17
BVpS0.79
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.34%
ROE -150.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.71%
FCFM N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.95%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.03
Quick Ratio 16
Altman-Z -4.58
F-Score5
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)30.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-50.29%
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.54%
EBIT Next 3Y90.23%
EBIT Next 5Y65.6%
FCF growth 1Y70.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.47%
OCF growth 3YN/A
OCF growth 5YN/A